Final analysis of the CLL2-GIVe trial: obinutuzumab, ibrutinib, and venetoclax for untreated CLL with del(17p)/TP53mut
- Resource Type
- Article
- Authors
- Huber, Henriette; Tausch, Eugen; Schneider, Christof; Edenhofer, Simone; von Tresckow, Julia; Robrecht, Sandra; Giza, Adam; Zhang, Can; Fürstenau, Moritz; Dreger, Peter; Ritgen, Matthias; Illmer, Thomas; Illert, Anna Lena; Dürig, Jan; Böttcher, Sebastian; Niemann, Carsten U.; Kneba, Michael; Al-Sawaf, Othman; Kreuzer, Karl-Anton; Fink, Anna-Maria; Fischer, Kirsten; Döhner, Hartmut; Hallek, Michael; Eichhorst, Barbara; Stilgenbauer, Stephan
- Source
- In Blood 14 September 2023 142(11):961-972
- Subject
- Clinical Trials and Observations
Lymphoid Neoplasia
- Language
- ISSN
- 0006-4971